Search research articles
Contact Us
Filters
Showing results (41-50 of 82) with videos related to
Page
of 9
Sort By:
Immunogenetics
|
June 20, 1998
HLA-DRB1*03, but not the TNFA -308 promoter gene polymorphism, confers protection against fistulising Crohn's disease
G Bouma, A C Poen, M A García-González, et al.
Human Immunology
|
October 18, 2024
The frequency of HLA-DQ7 in patients at risk of coeliac disease: A haplotype to be reckoned with for screening?
M D Rouvroye, A Roos, F Bergkamp, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1997
Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors
M G Bouma, T M Jeunhomme, D L Boyle, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 7, 2018
Use of Video-consultation is Feasible During Follow-up Care of Patients with a Neuroendocrine Tumour
G Bouma, L D de Hosson, H van Essen, et al.
Immunogenetics
|
September 2, 2000
TGFB1 gene polymorphisms and inflammatory bowel disease
M A García-González, J B Crusius, M H Strunk, et al.
Molecular Immunology
|
April 8, 2014
Excreted/secreted Trichuris suis products reduce barrier function and suppress inflammatory cytokine production of intestinal epithelial cells
I H Hiemstra, E J Klaver, K Vrijland, et al.
Scandinavian Journal of Gastroenterology
|
November 1, 1995
Differences in the intrinsic capacity of peripheral blood mononuclear cells to produce tumor necrosis factor alpha and beta in patients with inflammatory bowel disease and healthy controls
G Bouma, M Oudkerk Pool, J G Scharenberg, et al.
Clinical and Experimental Immunology
|
July 28, 2005
An increased MRP8/14 expression and adhesion, but a decreased migration towards proinflammatory chemokines of type 1 diabetes monocytes
G Bouma, J M C Coppens, W-K Lam-Tse, et al.
Alimentary Pharmacology & Therapeutics
|
April 5, 2013
Letter: allopurinol co-therapy is safe and effective in autoimmune hepatitis -- authors' reply
Y S de Boer, N M F van Gerven, N K H de Boer, et al.
Alimentary Pharmacology & Therapeutics
|
January 26, 2013
Allopurinol safely and effectively optimises thiopurine metabolites in patients with autoimmune hepatitis
Y S de Boer, N M F van Gerven, N K H de Boer, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 82) with videos related to
Sort By:
Page
of 9
Immunogenetics
|
June 20, 1998
HLA-DRB1*03, but not the TNFA -308 promoter gene polymorphism, confers protection against fistulising Crohn's disease
G Bouma, A C Poen, M A García-González, et al.
Human Immunology
|
October 18, 2024
The frequency of HLA-DQ7 in patients at risk of coeliac disease: A haplotype to be reckoned with for screening?
M D Rouvroye, A Roos, F Bergkamp, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1997
Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors
M G Bouma, T M Jeunhomme, D L Boyle, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 7, 2018
Use of Video-consultation is Feasible During Follow-up Care of Patients with a Neuroendocrine Tumour
G Bouma, L D de Hosson, H van Essen, et al.
Immunogenetics
|
September 2, 2000
TGFB1 gene polymorphisms and inflammatory bowel disease
M A García-González, J B Crusius, M H Strunk, et al.
Molecular Immunology
|
April 8, 2014
Excreted/secreted Trichuris suis products reduce barrier function and suppress inflammatory cytokine production of intestinal epithelial cells
I H Hiemstra, E J Klaver, K Vrijland, et al.
Scandinavian Journal of Gastroenterology
|
November 1, 1995
Differences in the intrinsic capacity of peripheral blood mononuclear cells to produce tumor necrosis factor alpha and beta in patients with inflammatory bowel disease and healthy controls
G Bouma, M Oudkerk Pool, J G Scharenberg, et al.
Clinical and Experimental Immunology
|
July 28, 2005
An increased MRP8/14 expression and adhesion, but a decreased migration towards proinflammatory chemokines of type 1 diabetes monocytes
G Bouma, J M C Coppens, W-K Lam-Tse, et al.
Alimentary Pharmacology & Therapeutics
|
April 5, 2013
Letter: allopurinol co-therapy is safe and effective in autoimmune hepatitis -- authors' reply
Y S de Boer, N M F van Gerven, N K H de Boer, et al.
Alimentary Pharmacology & Therapeutics
|
January 26, 2013
Allopurinol safely and effectively optimises thiopurine metabolites in patients with autoimmune hepatitis
Y S de Boer, N M F van Gerven, N K H de Boer, et al.
Page
of 9